🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 7 Days
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 7 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(448)
All (448)
Buys (31)
Sells (417)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
ILLUMINA, INC.
(ILMN)
Meister Keith A.
— Director
Aug 4, 2026
Sale
Shares
48,186
Price
$202.43
Total Value
$9.75M
Shares Held After
2,440,682
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ILLUMINA, INC.
(ILMN)
Meister Keith A.
— Director
Aug 4, 2026
Sale
Shares
67,725
Price
$201.44
Total Value
$13.64M
Shares Held After
2,488,868
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ILLUMINA, INC.
(ILMN)
Meister Keith A.
— Director
Aug 4, 2026
Sale
Shares
37,242
Price
$200.65
Total Value
$7.47M
Shares Held After
2,556,593
% of Holdings
1.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ILLUMINA, INC.
(ILMN)
Meister Keith A.
— Director
Aug 4, 2026
Sale
Shares
35,160
Price
$199.51
Total Value
$7.01M
Shares Held After
2,593,835
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ILLUMINA, INC.
(ILMN)
Meister Keith A.
— Director
Aug 4, 2026
Sale
Shares
166,501
Price
$198.24
Total Value
$33.01M
Shares Held After
2,628,995
% of Holdings
6.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ILLUMINA, INC.
(ILMN)
Meister Keith A.
— Director
Aug 4, 2026
Sale
Shares
27,854
Price
$197.48
Total Value
$5.50M
Shares Held After
2,795,496
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ILLUMINA, INC.
(ILMN)
Meister Keith A.
— Director
Aug 4, 2026
Sale
Shares
7,202
Price
$196.74
Total Value
$1.42M
Shares Held After
2,823,350
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NEOGENOMICS INC
(NEO)
Aunan Greg D
— Chief Accounting Officer
Aug 4, 2026
Sale
Shares
20,000
Price
$16.07
Total Value
$321.40K
Shares Held After
5,153
% of Holdings
79.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tiziana Life Sciences Ltd
(TLSA)
Elrifi Ivor
— Chief Executive Officer
Aug 4, 2026
Purchase
Shares
83,807
Price
$0.97
Total Value
$81.29K
Shares Held After
4,556,068
% of Holdings
1.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LABCORP HOLDINGS INC.
(LH)
Summy Amy B.
— EVP, Chief Marketing Officer
Aug 4, 2026
Sale
Shares
924
Price
$306.74
Total Value
$283.43K
Shares Held After
6,956
% of Holdings
11.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
NEOGEN CORP
(NEOG)
Nassif Mikheal
— Director
Aug 4, 2026
Purchase
Shares
370
Price
$11.81
Total Value
$4.37K
Shares Held After
1,074
% of Holdings
34.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Anteris Technologies Global Corp.
(AVR)
L1 Capital Pty Ltd
— 10% Owner
Aug 4, 2026
Sale
Shares
480,608
Price
$8.30
Total Value
$3.99M
Shares Held After
5,628,302
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BIOGEN INC.
(BIIB)
Minor Lloyd
— Director
Aug 4, 2026
Sale
Shares
593
Price
$200.96
Total Value
$119.17K
Shares Held After
2,689
% of Holdings
18.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Natera, Inc.
(NTRA)
Brophy Michael Burkes
— CHIEF FINANCIAL OFFICER
Aug 4, 2026
Sale
Shares
478
Price
$274.22
Total Value
$131.08K
Shares Held After
51,637
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
APTARGROUP, INC.
(ATR)
Prieur Marc
— Segment President
Aug 4, 2026
Sale
Shares
124
Price
$137.10
Total Value
$17.00K
Shares Held After
15,823
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
APTARGROUP, INC.
(ATR)
Prieur Marc
— Segment President
Aug 4, 2026
Sale
Shares
3,376
Price
$136.23
Total Value
$459.90K
Shares Held After
15,947
% of Holdings
17.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
CLARK IAN T
— Director
Aug 4, 2026
Sale
Shares
5,092
Price
$158.80
Total Value
$808.63K
Shares Held After
2,975
% of Holdings
63.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Guardant Health, Inc.
(GH)
CLARK IAN T
— Director
Aug 4, 2026
Sale
Shares
9,088
Price
$158.98
Total Value
$1.44M
Shares Held After
8,067
% of Holdings
53.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MBX Biosciences, Inc.
(MBX)
Azoulay Salomon
— Chief Medical Officer
Aug 4, 2026
Sale
Shares
370
Price
$65.77
Total Value
$24.33K
Shares Held After
14,399
% of Holdings
2.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
FATE THERAPEUTICS INC
(FATE)
Valamehr Bahram
— Director
Aug 4, 2026
Sale
Shares
43,947
Price
$2.46
Total Value
$108.10K
Shares Held After
591,815
% of Holdings
6.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Camblong Jurgi
— Director
Aug 4, 2026
Sale
Shares
20,000
Price
$6.92
Total Value
$138.41K
Shares Held After
3,472,822
% of Holdings
0.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
4D Molecular Therapeutics, Inc.
(FDMT)
Kirn David
— Director
Aug 4, 2026
Sale
Shares
26,842
Price
$10.23
Total Value
$274.60K
Shares Held After
844,895
% of Holdings
3.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Xu Zhenyu
— Chief Scientific Officer
Aug 4, 2026
Sale
Shares
10,000
Price
$6.92
Total Value
$69.17K
Shares Held After
600,887
% of Holdings
1.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SOPHiA GENETICS SA
(SOPH)
Verma Abhimanyu
— Chief Technology Officer
Aug 4, 2026
Sale
Shares
5,000
Price
$6.95
Total Value
$34.77K
Shares Held After
187,171
% of Holdings
2.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
HEALTHCARE SERVICES GROUP INC
(HCSG)
Kush Andrew
— EVP&Chief Operating Officer
Aug 4, 2026
Sale
Shares
15,598
Price
$23.24
Total Value
$362.50K
Shares Held After
22,741
% of Holdings
40.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Anika Therapeutics, Inc.
(ANIK)
Fischetti Gary P
— Director
Aug 4, 2026
Purchase
Shares
1,000
Price
$20.32
Total Value
$20.32K
Shares Held After
54,015
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BOSTON SCIENTIFIC CORP
(BSX)
Habiger David C
— Director
Aug 4, 2026
Purchase
Shares
140
Price
$48.59
Total Value
$6.80K
Shares Held After
15,060
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
SHOULDER INNOVATIONS, INC.
(SI)
Gilde Healthcare Holding B.V.
— 10% Owner
Aug 4, 2026
Sale
Shares
99,812
Price
$22.77
Total Value
$2.27M
Shares Held After
2,221,640
% of Holdings
4.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
299
Price
$520.49
Total Value
$155.63K
Shares Held After
324,443
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
517
Price
$519.50
Total Value
$268.58K
Shares Held After
324,742
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
1,446
Price
$518.40
Total Value
$749.60K
Shares Held After
325,259
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
3,142
Price
$517.50
Total Value
$1.63M
Shares Held After
326,705
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
2,456
Price
$516.59
Total Value
$1.27M
Shares Held After
329,847
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
605
Price
$515.50
Total Value
$311.88K
Shares Held After
332,303
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
675
Price
$514.43
Total Value
$347.24K
Shares Held After
332,908
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
182
Price
$513.39
Total Value
$93.44K
Shares Held After
333,583
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
ROTHBLATT MARTINE A
— Director
Aug 4, 2026
Sale
Shares
178
Price
$512.49
Total Value
$91.22K
Shares Held After
333,765
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
FATE THERAPEUTICS INC
(FATE)
TAHL CINDY
— Chief Legal and Compliance Officer
Aug 4, 2026
Sale
Shares
38,800
Price
$2.46
Total Value
$95.41K
Shares Held After
589,355
% of Holdings
6.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Korro Bio, Inc.
(KRRO)
Aiyar Ram
— Director
Aug 4, 2026
Sale
Shares
5,802
Price
$10.84
Total Value
$62.92K
Shares Held After
69,046
% of Holdings
7.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Evogene Ltd.
(EVGN)
RECANATI LEON
— Director
Aug 4, 2026
Purchase
Shares
800,000
Price
$0.50
Total Value
$400.00K
Shares Held After
883,886
% of Holdings
90.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
MERIT MEDICAL SYSTEMS INC
(MMSI)
Peterson Neil W.
— CHIEF OPERATING OFFICER
Aug 4, 2026
Sale
Shares
21,449
Price
$85.00
Total Value
$1.82M
Shares Held After
25,551
% of Holdings
45.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Hansen Gwenn
— Chief Scientific Officer
Aug 4, 2026
Sale
Shares
2,611
Price
$24.64
Total Value
$64.34K
Shares Held After
117,227
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
Hansen Gwenn
— Chief Scientific Officer
Aug 4, 2026
Sale
Shares
1,500
Price
$23.87
Total Value
$35.80K
Shares Held After
119,838
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
van Houte Hans
— Chief Financial Officer
Aug 4, 2026
Sale
Shares
2,967
Price
$24.65
Total Value
$73.13K
Shares Held After
40,166
% of Holdings
6.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Nurix Therapeutics, Inc.
(NRIX)
van Houte Hans
— Chief Financial Officer
Aug 4, 2026
Sale
Shares
1,794
Price
$23.89
Total Value
$42.86K
Shares Held After
43,133
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GENELUX Corp
(GNLX)
Yu Yong
— Chief Scientific Officer
Aug 4, 2026
Sale
Shares
653
Price
$2.94
Total Value
$1.92K
Shares Held After
268,371
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GENELUX Corp
(GNLX)
Cappello Joseph
— Chief Technical Officer
Aug 4, 2026
Sale
Shares
653
Price
$2.95
Total Value
$1.92K
Shares Held After
328,737
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
GENELUX Corp
(GNLX)
Zindrick Thomas
— President and CEO
Aug 4, 2026
Sale
Shares
3,023
Price
$2.95
Total Value
$8.91K
Shares Held After
1,260,890
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Jushi Holdings Inc.
(JUSH)
Barack Louis Jon
— President
Aug 4, 2026
Purchase
Shares
10,000
Price
$0.43
Total Value
$4.30K
Shares Held After
2,883,773
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tilray Brands, Inc.
(TLRY)
Merton Carl A
— Chief Financial Officer
Aug 4, 2026
Purchase
Shares
10,000
Price
$4.62
Total Value
$46.20K
Shares Held After
139,753
% of Holdings
7.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Next →
Showing 1–50 of 448 transactions (page 1 of 9)
Version: v26.7.3